glp-1 and cancer risk A very common question I get asked often is how effective are the weight loss drugs (specifically agonists Glucagon-like peptide 1 receptor agonists
Description
Preliminary studies suggest a beneficial role in obstructive sleep apnea management with reductions in the apnea-hypopnea index and potential improvements in other sleep-related outcomes
Legally yes, but enforcement varies
In humans, GLP-1 secretion in response to duodenal glucose delivery does not become robustly stimulated until the delivery rate overcomes the absorptive capacity of the duodenum, i.e
It could sometimes lead to gallstones or kidney problems
As a GLP-1 supplement in drop form for daily metabolic maintenance, it's well-suited
Ozempic works as a glucagon-like peptide that replaces a function that the GLP-1 in the body no longer performs
